These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1150 related articles for article (PubMed ID: 23490028)

  • 1. Comparison of in-hospital outcomes with low-dose fibrinolytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Bhatt NS; Solhpour A; Balan P; Barekatain A; McCarthy JJ; Sdringola S; Denktas AE; Smalling RW; Anderson HV
    Am J Cardiol; 2013 Jun; 111(11):1576-9. PubMed ID: 23490028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of outcomes for patients ≥75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Solhpour A; Chang KW; Balan P; Cai C; Sdringola S; Denktas AE; Smalling RW; Anderson HV
    Am J Cardiol; 2014 Jan; 113(1):60-3. PubMed ID: 24207074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Solhpour A; Chang KW; Arain SA; Balan P; Zhao Y; Loghin C; McCarthy JJ; Vernon Anderson H; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):709-715. PubMed ID: 27028120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
    Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the radial approach for the performance of primary PCI for STEMI.
    Cafri C; Zahger D; Merkin M; Weinstein JM; Kobal S; Ilia R
    J Invasive Cardiol; 2013 Mar; 25(3):150-3. PubMed ID: 23468447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE).
    Czarnecki A; Welsh RC; Yan RT; DeYoung JP; Gallo R; Rose B; Grondin FR; Kornder JM; Wong GC; Fox KA; Gore JM; Goodman SG; Yan AT; ;
    Can J Cardiol; 2012; 28(1):40-7. PubMed ID: 22129488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.
    Kent DM; Ruthazer R; Griffith JL; Beshansky JR; Concannon TW; Aversano T; Grines CL; Zalenski RJ; Selker HP
    Am J Cardiol; 2008 Mar; 101(6):790-5. PubMed ID: 18328842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cardiac care variation on ST-elevation myocardial infarction outcomes in Malaysia.
    Selvarajah S; Fong AY; Selvaraj G; Haniff J; Hairi NN; Bulgiba A; Bots ML
    Am J Cardiol; 2013 May; 111(9):1270-6. PubMed ID: 23415636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regional system for delivery of primary percutaneous coronary intervention in ST-elevation myocardial infarction: STEMI-St. Cloud.
    Aplin R; Tiede D; Lovitz C; Gartner M; Robinson D; Xu H; Martin P; Erickson B; Schmidt W; Pelzel J; Wendt D; Mahowald J
    J Invasive Cardiol; 2009 Dec; 21(12):639-44. PubMed ID: 19966367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
    Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network).
    Siontis KC; Barsness GW; Lennon RJ; Holmen JL; Wright RS; Bell MR; Gersh BJ
    Am J Cardiol; 2016 Jun; 117(12):1904-10. PubMed ID: 27131614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis followed by coronary angiography versus primary percutaneous coronary intervention in non-anterior ST-elevation myocardial infarction.
    Schwartz R; Weiss AT; Leibowitz D; Rot D; Pollak A; Lotan C; Alcalai R
    J Invasive Cardiol; 2013 Dec; 25(12):632-6. PubMed ID: 24296382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
    Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of reperfusion strategies on in-hospital outcome in ST-elevation myocardial infarction in a context of interhospital network: data from the prospective VENERE registry (VENEto acute myocardial infarction REgistry].
    Di Pede F; Olivari Z; Schievano E; Spolaore P; Cacciavillani L; La Vecchia L; Bruni A; Zuin G; Franco GF; Palatini O; Morando G; Tinto M; Rossi M; Guarnerio M;
    Ital Heart J Suppl; 2005 Dec; 6(12):804-11. PubMed ID: 16444924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.